Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
VKTX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

19.82

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

0.27

EPS Last/This Y

-1.53

EPS This/Next Y

0.16

Price

28.76

Target Price

94.29

Analyst Recom

1.21

Performance Q

-19.31

Upside

-287.7%

Beta

0.73

Ticker: VKTX



18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-18VKTX28.680.160.58144675
2026-05-19VKTX28.40.220.05162634
2026-05-20VKTX29.440.220.11165066
2026-05-21VKTX30.680.210.30168034
2026-05-22VKTX30.920.210.25170468
2026-05-26VKTX30.820.220.13157621
2026-05-27VKTX31.660.210.33162733
2026-05-28VKTX32.190.220.21167575
2026-05-29VKTX32.710.210.07173154
2026-06-02VKTX29.260.210.41170162
2026-06-03VKTX29.320.220.32175744
2026-06-04VKTX29.760.220.20176617
2026-06-05VKTX28.450.220.30179377
2026-06-08VKTX29.260.210.11169055
2026-06-09VKTX29.220.210.23174293
2026-06-10VKTX27.730.210.67176526
2026-06-11VKTX28.610.210.18179884
2026-06-12VKTX28.750.210.48182136
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-18VKTX28.68-112.1-57.7-4.73
2026-05-19VKTX28.40-112.1-89.7-4.73
2026-05-20VKTX29.43-112.1-124.7-4.73
2026-05-21VKTX30.67-112.1-128.6-4.73
2026-05-22VKTX30.90-112.1-102.5-4.73
2026-05-26VKTX30.81-112.1-95.1-4.73
2026-05-27VKTX31.65-112.1-117.7-4.73
2026-05-28VKTX32.17-112.1-108.9-4.73
2026-05-29VKTX32.72-112.1-109.5-4.73
2026-06-01VKTX31.27-100.0-64.0-4.72
2026-06-02VKTX29.32-100.0-51.2-4.72
2026-06-03VKTX29.34-100.0-98.4-4.72
2026-06-04VKTX29.79-100.0-108.4-4.72
2026-06-05VKTX28.45-100.0-63.5-4.72
2026-06-08VKTX29.25-100.0-118.4-4.72
2026-06-09VKTX29.23-100.0-96.7-4.72
2026-06-10VKTX27.72-100.0-57.9-4.72
2026-06-11VKTX28.60-100.0-120.4-4.72
2026-06-12VKTX28.76-100.0-100.9-4.72
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-18VKTX-9.94-1.9620.07
2026-05-19VKTX-9.98-1.9620.07
2026-05-20VKTX-9.98-1.9620.07
2026-05-21VKTX-9.98-1.9620.07
2026-05-22VKTX-9.98-1.9620.07
2026-05-26VKTX-9.981.0720.07
2026-05-27VKTX-9.981.0720.07
2026-05-28VKTX-9.981.0719.74
2026-05-29VKTX-9.981.0719.74
2026-06-02VKTX-9.980.3019.74
2026-06-03VKTX-9.980.3019.74
2026-06-04VKTX-9.980.3019.74
2026-06-05VKTX-9.980.3019.74
2026-06-08VKTX-9.980.3219.74
2026-06-09VKTX-9.980.3219.74
2026-06-10VKTX-9.980.3219.82
2026-06-11VKTX-9.980.3219.82
2026-06-12VKTX-9.980.3219.82
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS​

-1.37

Avg. EPS Est. Current Quarter

-1.21

Avg. EPS Est. Next Quarter

-1.1

Insider Transactions

-9.98

Institutional Transactions

0.32

Beta

0.73

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

6

Growth Score

19

Sentiment Score

30

Actual DrawDown %

71.1

Max Drawdown 5-Year %

-78.9

Target Price

94.29

P/E

Forward P/E

PEG

P/S

P/B

6.64

P/Free Cash Flow

EPS

-4.15

Average EPS Est. Cur. Y​

-4.72

EPS Next Y. (Est.)

-4.57

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.51

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

-100.9
◆ VKTX Healthcare
$28.75
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
17/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
8/10
RSI
42.3
Range 1M
31.7%
Sup Dist
4.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
15 /100
WEAK
Momentum
0/25
Growth
4/30
Estimates
0/20
Inst/Vol
3/15
Options
8/10
EPS Yr
-49%
EPS NY
-0.4%
52W%
30.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +228% upside
Quality
2/30
Valuation
15/30
Growth
0/25
Stability
8/10
LT Trend
0/5
Upside
+228%
Quality
6
Click a card to see score breakdown Full Analysis →
Viking Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
VKTX

Latest News

—
Caricamento notizie per VKTX…
stock quote shares VKTX – Viking Therapeutics, Inc. Stock Price stock today
news today VKTX – Viking Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics, Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics, Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading